Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Oct;19(10):2454-2467.
doi: 10.1111/jth.15432. Epub 2021 Jul 20.

D-dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta-analysis

Affiliations
Meta-Analysis

D-dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta-analysis

Marta Bellesini et al. J Thromb Haemost. 2021 Oct.

Abstract

Background: The usefulness of D-dimer measurement to rule out venous thromboembolism (VTE) during pregnancy is debated.

Objectives: We performed a systematic review and meta-analysis to investigate the safety of D-dimer to rule out acute VTE in pregnant women with suspected pulmonary embolism and/or deep vein thrombosis.

Methods: Two reviewers independently identified studies through PubMed and Embase until June 2021, week 1. We supplemented our search by manually reviewing reference lists of all retrieved articles, clinicalTrials.gov, and reference literature. Prospective or retrospective studies in which a formal diagnostic algorithm was used to evaluate the ability of D-dimer to rule out VTE during pregnancy were eligible.

Results: We identified 665 references through systematic database and additional search strategies; 45 studies were retrieved in full, of which four were included, after applying exclusion criteria. Three studies were prospective, and one had a retrospective design. The 3-month thromboembolic rate in pregnant women left untreated after a negative D-dimer was 1/312 (0.32%; 95% CI, 0.06-1.83). The pooled estimate values were 99.5% for sensitivity (95% CI, 95.0-100.0; I², 0%) and 100% for negative predictive value (95% CI, 99.19-100.0; I², 0%). The prevalence of VTE and the yield of D-dimer were 7.4% (95% CI, 3.8-12; I², 83%) and 34.2% (95% CI, 15.9-55.23; I², 89%) respectively.

Conclusion: Our results suggest that D-dimer allows to safely rule out VTE in pregnant women with suspected VTE and a disease prevalence consistent with a low/intermediate or unlikely pretest probability.

Keywords: D-dimer.; clinical probability; diagnostic strategy; pregnancy; pulmonary embolism.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflicts of interest. The corresponding author had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Figures

FIGURE 1
FIGURE 1
PRISMA flow diagram of study selection, included and excluded studies
FIGURE 2
FIGURE 2
Quality assessment, QUADAS‐2 results
FIGURE 3
FIGURE 3
Forest plot of the meta‐analysis of sensitivities (A), of negative predictive values (NPV) (B), and of the diagnostic yield of D‐dimer

Comment in

References

    1. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30‐year population‐based study. Ann Intern Med. 2005;143:697‐706. - PubMed
    1. Liu S, Rouleau J, Joseph KS, et al. Epidemiology of pregnancy‐associated venous thromboembolism: a population‐based study in Canada. J Obstet Gynaecol Can. 2009;31:611‐620. - PubMed
    1. Sultan AA, West J, Tata LJ, Fleming KM, Nelson‐Piercy C, Grainge MJ. Risk of first venous thromboembolism in and around pregnancy: a population‐based cohort study. Br J Haematol. 2012;156:366‐373. - PubMed
    1. MBRRACE‐UK Update . Key messages from the UK and Ireland Confidential Enquiries into Maternal Death and Morbidity 2017. Obstet Gynaecol. 2018;20:75‐79.
    1. Soma‐Pillay P, Nelson‐Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Afr. 2016;27:89‐94. - PMC - PubMed

Substances